[membership level=”0,4″][The content continues for paid members only.]
Login or Subscribe [/membership][membership level=”1,5,6,7,8,9,10,11,12″][membership]
India’s largest state, Maharashtra, has cut the time its FDA takes to process manufacturing licensing applications and “slashed” its backlog by adopting an online system, The Asian Age reported in early April. Over the six months the agency has used the system, it says that it has cleared 15,000 applications. Maharashtra’s FDA has implemented an online “Extended Licensing Node” (XLN) in its Konkan district and plans to roll out the technology across the state over the next few months. The Drug Controller General of India (DCGI) is also planning to take licensing applications online – a switch he hopes to make in the next two years, The Asian Age reported.
[/membership]
INTERNATIONAL PHARMACEUTICAL QUALITY
Inside the Global Regulatory Dialogue